OVID Historical PE Ratio image   This OVID PE ratio history page last updated 8/22/2024
OVID PE History Chart
PeriodPriceGAAPTTMPE
Q2 2024
8/13/2024
0.880.12-0.43NA
Q1 2024
5/14/2024
3.23-0.17-0.73NA
Q4 2023
3/8/2024
3.08-0.22-0.75NA
Q3 2023
11/3/2023
3.57-0.16-0.69NA
Q2 2023
8/4/2023
3.50-0.18-0.70NA
Q1 2023
5/5/2023
3.63-0.19-0.73NA
Q4 2022
3/13/2023
2.01-0.16-0.77NA
Q3 2022
11/8/2022
1.49-0.17-0.99NA
Q2 2022
8/9/2022
2.18-0.21-0.99NA
Q1 2022
5/10/2022
2.78-0.23-1.01NA
Q4 2021
3/15/2022
3.13-0.381.751.8
Q3 2021
11/10/2021
3.50-0.171.792.0
Q2 2021
8/16/2021
3.74-0.231.682.2
Q1 2021
5/13/2021
3.302.531.502.2
Q4 2020
3/15/2021
4.12-0.34-1.40NA
Q3 2020
11/12/2020
5.42-0.28-1.41NA
Q2 2020
8/10/2020
7.14-0.41-1.56NA
Q1 2020
5/7/2020
3.52-0.37-1.49NA
Q4 2019
3/11/2020
2.68-0.35-1.58NA
Q3 2019
11/8/2019
2.55-0.43-1.75NA
Q2 2019
8/7/2019
1.91-0.34-1.85NA
Q1 2019
5/7/2019
1.89-0.46-2.04NA
Q4 2018
3/7/2019
1.99-0.52-2.12NA
Q3 2018
11/8/2018
5.56-0.53-2.05NA
Q2 2018
8/9/2018
6.02-0.53-1.90NA
Q1 2018
5/8/2018
8.95-0.54-1.94NA
Q4 2017
3/29/2018
7.07-0.45-4.88NA
Q3 2017
11/9/2017
7.44-0.38NANA
Q2 2017
8/10/2017
5.32-0.57NANA
Q1 2017
6/13/2017
14.40-3.48NANA
OVID Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2024
8/13/2024
0.880.120.481.8
Q1 2024
5/14/2024
3.23-0.17-0.68NA
Q4 2023
3/8/2024
3.08-0.22-0.88NA
Q3 2023
11/3/2023
3.57-0.16-0.64NA
Q2 2023
8/4/2023
3.50-0.18-0.72NA
Q1 2023
5/5/2023
3.63-0.19-0.76NA
Q4 2022
3/13/2023
2.01-0.16-0.64NA
Q3 2022
11/8/2022
1.49-0.17-0.68NA
Q2 2022
8/9/2022
2.18-0.21-0.84NA
Q1 2022
5/10/2022
2.78-0.23-0.92NA
Q4 2021
3/15/2022
3.13-0.38-1.52NA
Q3 2021
11/10/2021
3.50-0.17-0.68NA
Q2 2021
8/16/2021
3.74-0.23-0.92NA
Q1 2021
5/13/2021
3.302.5310.120.3
Q4 2020
3/15/2021
4.12-0.34-1.36NA
Q3 2020
11/12/2020
5.42-0.28-1.12NA
Q2 2020
8/10/2020
7.14-0.41-1.64NA
Q1 2020
5/7/2020
3.52-0.37-1.48NA
Q4 2019
3/11/2020
2.68-0.35-1.40NA
Q3 2019
11/8/2019
2.55-0.43-1.72NA
Q2 2019
8/7/2019
1.91-0.34-1.36NA
Q1 2019
5/7/2019
1.89-0.46-1.84NA
Q4 2018
3/7/2019
1.99-0.52-2.08NA
Q3 2018
11/8/2018
5.56-0.53-2.12NA
Q2 2018
8/9/2018
6.02-0.53-2.12NA
Q1 2018
5/8/2018
8.95-0.54-2.16NA
Q4 2017
3/29/2018
7.07-0.45-1.80NA
Q3 2017
11/9/2017
7.44-0.38-1.52NA
Q2 2017
8/10/2017
5.32-0.57-2.28NA
Q1 2017
6/13/2017
14.40-3.48-13.92NA
Quotes delayed 20 minutes

Email EnvelopeFree OVID Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Ovid Therapeutics (OVID) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

OYST PE Ratio History
PACB PE Ratio History
PACS PE Ratio History
PAHC PE Ratio History
PALI PE Ratio History
PASG PE Ratio History
PAVM PE Ratio History
PBH PE Ratio History
PBLA PE Ratio History
PBYI PE Ratio History
On this page we presented the OVID PE Ratio History information for Ovid Therapeutics' stock. The average OVID PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 1.1. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average OVID PE ratio history based on this TTM earnings result method is 2.0. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this OVID PE ratio history result, against the recent PE: when this page was posted on 8/21/2024, the most recent closing price for OVID had been 1.19, and the most recent quarterly earnings result, annualized, was 0.48. Meanwhile, the most recent TTM earnings summed to 1.75. From these numbers, we calculate the recent OVID PE on 8/21/2024 based on annualized quarterly EPS was 2.5. Based on OVID's history, that recent PE is elevated relative to the historical average, with the recent PE 127.3% higher than the historical average PE across our data set for Ovid Therapeutics. Looking at the recent OVID PE on 8/21/2024 based on TTM EPS, we calculate the ratio at 0.7. Based on OVID's history, that recent PE is low relative to the historical average, with the recent PE 65.0% lower than the average PE across our Ovid Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on OVID or any other given stock, valuation analysis for OVID can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Ovid Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for OVID. Thanks for visiting, and the next time you need to research OVID PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: QSY shares outstanding history, Funds Holding CRBN, GCAP Price Target.

 

OVID PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.